MRI-identified multidimensional nodal features: predict survival and concurrent chemotherapy benefit for stage II nasopharyngeal carcinoma: LN feature-based nomogram for stage II NPC . Radiol Oncol [Internet]. 2022 Dec. 5 [cited 2026 Sep. 25];56(4):479-87. Available from: https://www.radioloncol.com/index.php/ro/article/view/3963